PREVALENCE AND OUTCOMES OF ACUTE STEMI PATIENTS WHO WERE ON CHRONIC VITAMIN K ANTAGONIST THERAPY AT THE TIME OF PRESENTATION

Prevalence and outcomes of patients who are on chronic Vitamin K antagonist therapy (VKA) in acute STEMI populations are largely unknown as they were excluded from prospective clinical trials. It is unclear whether chronic VKA is associated with increased longterm mortality. In a large academic